Get the Stockscreener App
2.315
3.96%
-0.085
Whitehawk Therapeutics Inc stock is traded at $2.315, with a volume of 36,731.
It is down -3.96% in the last 24 hours and up +17.60% over the past month.
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
See More
Previous Close:
$2.40
Open:
$2.33
24h Volume:
36,731
Relative Volume:
0.02
Market Cap:
$108.87M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-4.75%
1M Performance:
+17.60%
6M Performance:
+33.62%
1Y Performance:
+0.00%
1-Day Range:
$2.31
$2.39
1-Week Range:
$2.18
$2.49
52-Week Range:
$1.39
$3.7699
Whitehawk Therapeutics Inc Stock (WHWK) Company Profile
Name
Whitehawk Therapeutics Inc
Sector
Industry
Phone
551-321-2234
Address
2 HEADQUARTERS PLAZA, MORRISTOWN
Compare WHWK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WHWK
Whitehawk Therapeutics Inc
|
2.31 | 113.11M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.69 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.02 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.18 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.84 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.89 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Whitehawk Therapeutics Inc Stock (WHWK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-21-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-21-24 | Downgrade | TD Cowen | Buy → Hold |
| Dec-15-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-11-22 | Initiated | Jefferies | Buy |
| Oct-01-21 | Initiated | Cowen | Outperform |
| Sep-14-21 | Initiated | Ladenburg Thalmann | Buy |
| Sep-08-21 | Initiated | Piper Sandler | Overweight |
View All
Whitehawk Therapeutics Inc Stock (WHWK) Latest News
Multi asset correlation models including Whitehawk Therapeutics Inc.July 2025 Patterns & Fast Moving Trade Plans - newser.com
Can Whitehawk Therapeutics Inc. stock hit record highs againEarnings Risk Report & Fast Gain Stock Tips - newser.com
Whitehawk Therapeutics Inc.’s volatility index tracking explainedEarnings Beat & Risk Controlled Stock Alerts - newser.com
Using R and stats models for Whitehawk Therapeutics Inc. forecasting2025 Price Action Summary & High Return Trade Guides - newser.com
Whitehawk Therapeutics Inc. stock trend outlook and recovery path2025 Buyback Activity & Reliable Entry Point Alerts - newser.com
Applying chart zones and confluence areas to Whitehawk Therapeutics Inc.July 2025 Chart Watch & Daily Market Momentum Tracking - newser.com
Can machine learning forecast Whitehawk Therapeutics Inc. recovery2025 Top Gainers & Fast Entry Momentum Alerts - newser.com
Can Whitehawk Therapeutics Inc. stock sustain institutional interestPortfolio Gains Summary & Reliable Intraday Trade Alerts - newser.com
Whitehawk Therapeutics (NASDAQ:WHWK) Downgraded to Strong Sell Rating by Wall Street Zen - MarketBeat
Candlestick signals on Whitehawk Therapeutics Inc. stock todayJuly 2025 Retail & Daily Stock Trend Reports - newser.com
Hedge funds investors own a significant stake of 37% in Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) - Yahoo Finance
Using data tools to time your Whitehawk Therapeutics Inc. exitJuly 2025 Trade Ideas & Safe Capital Growth Plans - newser.com
Will Whitehawk Therapeutics Inc. stock remain a Wall Street favoriteWeekly Profit Analysis & AI Powered Market Entry Strategies - newser.com
Can Whitehawk Therapeutics Inc. stock outperform in 2025 bull marketCEO Change & Free High Return Stock Watch Alerts - newser.com
Can Whitehawk Therapeutics Inc. stock beat market expectations this quarterMarket Activity Recap & AI Optimized Trade Strategies - newser.com
What Fibonacci levels say about Whitehawk Therapeutics Inc. reboundJuly 2025 Movers & Daily Stock Trend Reports - newser.com
Whitehawk Therapeutics Inc expected to post earnings of 7 cents a shareEarnings Preview - TradingView
Tempus AI’s Strategic Collaboration with Whitehawk Therapeutics Bolsters Buy Rating with Promising Oncology Advances - NewsBreak: Local News & Alerts
Smart tools for monitoring Whitehawk Therapeutics Inc.’s price actionForecast Cut & AI Driven Stock Movement Reports - newser.com
How buyback programs support Whitehawk Therapeutics Inc. (3350) stockJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com
Is Buying Stock In Whitehawk Therapeutics Inc (WHWK) A Good Move Today? - fostersleader.com
Why Whitehawk Therapeutics Inc. stock is a must watch in 2025Treasury Yields & Risk Managed Investment Strategies - Fundação Cultural do Pará
Tempus AI-Whitehawk Therapeutics Data Partnership Could Be a Game Changer for Tempus AI (TEM) - Yahoo Finance
Whitehawk Therapeutics, Inc. News — HAM:3350 - TradingView
Whitehawk Therapeutics Inc Stock (WHWK) Financials Data
There is no financial data for Whitehawk Therapeutics Inc (WHWK). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.03%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):